Curis Inc reports results for the quarter ended June 30 - Earnings Summary

• Curis Inc CRIS reported a quarterly adjusted loss of 68 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.03. The mean expectation of five analysts for the quarter was for a loss of 89 cents per share. Wall Street expected results to range from $-1.11 to -74 cents per share.

• Revenue rose 8% to $2.75 million from a year ago; analysts expected $2.64 million.

• Curis Inc's reported EPS for the quarter was a loss of 68 cents​.

• The company reported a quarterly loss of $8.59 million.

• Curis Inc shares had fallen by 31.0% this quarter and lost 47.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Curis Inc is $17.00, about 90.6% above its last closing price of $1.60

This summary was machine generated from LSEG data August 5 at 02:21 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)